News
Morphic Therapeutic Announced The Presentation Of New Data Demonstrating Novel Real-Time Visualization Of Small Molecule α4β7 Inhibition Of Gut-Trafficking Cells
21 May 24
Biotech, News, General
Morphic Holding Q1 2024 GAAP EPS $(0.91) Beats $(0.94) Estimate
25 Apr 24
Earnings, Earnings Beats, News
Canaccord Genuity Maintains Buy on Morphic Holding, Lowers Price Target to $66
8 Mar 24
News, Price Target, Analyst Ratings
Press releases
Morphic to Participate in Jefferies Global Healthcare Conference
31 May 24
News, Press Releases
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
25 Apr 24
Earnings, Press Releases
MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholders
23 Apr 24
News, Legal, Press Releases
Ademi LLP Investigates Claims of Securities Fraud against Morphic Holding, Inc.
2 Apr 24
Press Releases
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
26 Mar 24
Press Releases
MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF)
20 Mar 24
News, Legal, Press Releases
Morphic to Participate in March Investor Conferences
5 Mar 24
News, Press Releases